8403.TWO TWO
ShareHope Medicine Co., Ltd.
1W: -0.5%
1M: -1.1%
3M: -3.3%
YTD: -19.2%
1Y: -25.0%
3Y: -39.8%
5Y: -15.7%
NT$18.90 ($0.59)
+0.00 (+0.00%)
Weekly Expected Move ±0.9%
NT$19
NT$19
NT$19
NT$19
NT$19
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$364M
+36.5% ▲
5Y CAGR: -12.7%
Capital Expenditures
$132M
-41.7% ▼
5Y CAGR: -18.4%
Free Cash Flow
$232M
+33.8% ▲
5Y CAGR: -8.1%
Dividends Paid
$69M
-27.3% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$121M
-257.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $233M | $294M | $109M | $174M | $150M |
| Depreciation & Amort. | $305M | $306M | $321M | $308M | $268M |
| Stock-Based Comp. | $3M | $0 | $0 | $0 | $0 |
| Change in Working Capital | $20M | $63M | -$141M | $2M | -$27M |
| Other Non-Cash Items | -$142M | -$18M | -$31M | -$217M | -$27M |
| Operating Cash Flow | $360M | $642M | $257M | $267M | $364M |
| — Investing Activities — | |||||
| Capital Expenditures | -$138M | -$1.3B | -$277M | -$83M | -$124M |
| Acquisitions (Net) | $8M | $120M | -$12M | $105M | -$20M |
| Investment Purchases | -$138M | -$140M | -$70M | -$44M | -$128M |
| Investment Sales | $85M | $33M | $98M | $68M | $15M |
| Other Investing | -$131M | $74M | $34M | -$11M | $136M |
| Investing Cash Flow | -$321M | -$1.4B | -$228M | $35M | -$121M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$215M | $872M | $224M | -$91M | -$175M |
| Stock Repurchased | -$103M | $0 | -$227M | -$9M | $0 |
| Dividends Paid | -$103M | -$59M | -$62M | -$54M | -$69M |
| Other Financing | $154M | -$107M | -$115M | -$73M | -$116M |
| Financing Cash Flow | -$163M | $706M | -$180M | -$227M | -$360M |
| Net Change in Cash | -$129M | -$22M | -$152M | $77M | -$121M |
| Cash End of Period | $1.6B | $1.5B | $1.4B | $1.5B | $1.3B |
| Free Cash Flow | $208M | -$642M | -$20M | $174M | $232M |